FdaApplication
ANDA 202300
Identifiers
- fda_app_no: ANDA202300
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS OF NEW YORK LLC |
| application_type | ANDA |
| approval_date | 2011-12-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| IBUPROFEN | IBUPROFEN | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE;ORAL |
1 product